Make sure ASD and VSD closure devices are FDA-approved

Why This Topic Matters

Knowing which closure devices are FDA-approved helps cardiology practices reduce documentation and billing risk when reporting these procedures. The article also helps readers understand the coding and reimbursement context surrounding these congenital heart defect interventions.

Article Sections

1. FDA-approved closure devices for atrial septal defects

   This section discusses approved and investigational device options in the context of atrial septal defect closure procedures. It focuses on the device landscape relevant to cardiology practices and FDA authorization status.

2. FDA-approved closure devices for ventricular septal defects

   This section covers device options for ventricular septal defect closure and distinguishes approved devices from those still under investigation. It places the discussion in the setting of interventional cardiology and congenital defect repair.

3. VSD and ASD and how it affects your patient

   This section provides general clinical background on atrial and ventricular septal defects and how they affect heart function. It explains the broader congenital heart disease context for the procedures discussed earlier.